The HIV Medicine Association is pleased to recognize three members during IDWeek 2023 for their contributions to advancing the field of HIV medicine.

The HIV Medicine Association is pleased to announce Allison Agwu, MD, ScM, FAAP, FIDSA, as its new chair. The Association also elected a new vice chair and named five new directors. HIVMA addresses health disparities and inequities in its mission to end the HIV epidemic. 

Personal beliefs and health care system barriers drive antibiotic use without a prescription, according to a new qualitative study.

A newly approved vaccine can substantially reduce the clinical and economic burden of lower respiratory tract disease caused by RSV, according to new findings presented at IDWeek 2023.

The Senate’s FY 2024 Labor, Health and Human Services and State and Foreign Operations appropriations bills largely flat fund ID programs at FY 2023 levels and provide a few modest increases.

IDSA is disappointed that the House Labor, Health and Human Services Subcommittee did not fund the Bio-Preparedness Workforce Pilot Program in its FY 2024 appropriations bill, missing an opportunity to close the widening ID workforce gap.

Breakthrough research presented at the International AIDS Society’s 2023 Conference on HIV Science in Brisbane, Australia this week demonstrates the significant advances and scientific achievements recently made in HIV science.

The Infectious Diseases Society of America is pleased to share the next step in its ongoing journey to reduce its environmental footprint. Beginning in January 2024, IDSA’s two print journals, Clinical Infectious Diseases and The Journal of Infectious Diseases, will move from 24 issues per year to 12.